Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 20;133(18):2189-2196.
doi: 10.1097/CM9.0000000000000983.

Systemic lupus erythematosus: year in review 2019

Yong Fan  1 , Yan-Jie Hao, Zhuo-Li Zhang
Affiliations
Review

Systemic lupus erythematosus: year in review 2019

Yong Fan et al. Chin Med J (Engl). .

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease with extreme heterogeneity and potentially involvement of any organ or system. Numerous unanswered questions and challenges in SLE always prompt further exploration. In 2019, great progress in various aspects of SLE emerged. Both the classification criteria and management recommendation for SLE were updated. New promising medications have been widely developed and tested, although subsequent clinical studies are warranted. As an emerging number of most notable studies in SLE were published in both clinical area and basic research in 2019, we aim to summarize the highest quality data on SLE regarding novel insights of pathogenesis, updated recommendations, hot-spot issues on clinical manifestations, new understanding of disease prognosis, and most importantly, the therapeutic advances in SLE in this review.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

None
Zhuo-Li Zhang, professor and director of department of Rheumatology and Clinical Immunology in Peking University First Hospital. She is also the vice-president and secretary general of Chinese Rheumatology Association.
See this image and copyright information in PMC

References

    1. Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. Systemic lupus erythematosus. Nat Rev Dis Primers 2016; 2:16039.doi: 10.1038/nrdp.2016.39. - PubMed
    1. Mak A, Cheung MW, Chiew HJ, Liu Y, Ho RC. Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s. Semin Arthritis Rheum 2012; 41:830–839. doi: 10.1016/j.semarthrit.2011.11.002. - PubMed
    1. Mu L, Hao Y, Fan Y, Huang H, Yang X, Xie A, et al. Mortality and prognostic factors in Chinese patients with systemic lupus erythematosus. Lupus 2018; 27:1742–1752. doi: 10.1177/0961203318789788. - PubMed
    1. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 2019; 78:1151–1159. doi: 10.1136/annrheumdis-2018-214819. - PubMed
    1. Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 2019; 78:736–745. doi: 10.1136/annrheumdis-2019-215089. - PubMed

MeSH terms